<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04084561</url>
  </required_header>
  <id_info>
    <org_study_id>18-8004</org_study_id>
    <secondary_id>1U54CA221705-01A1</secondary_id>
    <nct_id>NCT04084561</nct_id>
  </id_info>
  <brief_title>Risk Communication in African American Smokers</brief_title>
  <official_title>Nicotine Dependence and Lung Cancer Genetics in African Americans</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to understand the effects of learning about one's genetic risk for lung cancer
      that is specific to their ancestry. Participants will be given hypothetical personalized
      genetic risk results and ask to think about how they might respond to such information if
      they actually received such results.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study aims to understand the effects of learning about one's genetic risk for lung cancer
      that is specific to their ancestry. Smokers will be randomized to receive hypothetical
      information about their genetic status and consider how they think they would respond if such
      results were actually presented to them. They will be randomly assigned to receive one of
      four sets of hypothetical genetic results: 1) High risk of lung cancer and high genetic
      African ancestry, 2) High risk of lung cancer and low genetic African ancestry, 3) Low risk
      of lung cancer and high genetic African ancestry, or 4) Low risk of lung cancer and low
      genetic African ancestry. After being given this hypothetical information, participants will
      complete brief questionnaires assessing perceived risk of lung cancer, worry about cancer,
      psychological distress, and motivation to quit smoking.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">August 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Motivation to Quit Smoking</measure>
    <time_frame>immediately following intervention</time_frame>
    <description>use self report 7 item (condition options) MTSS (Motivation to Stop Smoking) Scale with yes/no option to determine the quitting intention condition</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>HRHA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Risk, High Ancestry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LRLA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low Risk, Low Ancestry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HRLA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>High Risk, Low Ancestry</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LRHA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Low Risk, High Ancestry</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HRHA</intervention_name>
    <description>participants will be asked to consider a hypothetical scenario in which genetic test results reveal that: 1) they carry genotypes that place African American smokers at a particularly high (~50%-80%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly high concordance with African heritage (~90%).</description>
    <arm_group_label>HRHA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>LRLA</intervention_name>
    <description>participants will be asked to consider a scenario in which genetic test results reveal that: 1) they are at normal (~7%-10%) risk for the development of lung cancer, and 2) their genetic profile reflects a particularly low concordance with African heritage (~10%).</description>
    <arm_group_label>LRLA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HRLA</intervention_name>
    <description>participants will receive &quot;High Risk, Low Ancestry (HRLA)&quot; hypothetical</description>
    <arm_group_label>HRLA</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>LRHA</intervention_name>
    <description>participants will receive &quot;Low Risk, High Ancestry (HRLA)&quot; hypothetical</description>
    <arm_group_label>LRHA</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age minimum

          -  Self-report African American

          -  Report smoking at least 100 lifetime cigarettes

        Exclusion Criteria:

          -  Report history of cancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Camille Ragin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fox Chase Cancer Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Grace X Ma, PhD</last_name>
    <phone>215-707-6493</phone>
    <email>grace.ma@temple.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hunter College</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joel Erblich, PhD, MPH</last_name>
      <phone>212-772-5550</phone>
      <email>jerblich@hunter.cuny.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fox Chase Cancer Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Camille Ragin, PhD</last_name>
      <phone>215-728-1148</phone>
      <email>Camille.Ragin@fccc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>September 6, 2019</study_first_submitted>
  <study_first_submitted_qc>September 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 10, 2019</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

